Debate: PCI vs CABG: a moving target, but we are gaining
The treatment of patients with coronary artery disease continues to evolve; all three strategies – medical therapy, surgical revascularization, and percutaneous coronary intervention – have changed. Medical therapy with intense risk-factor modification and treatment with a statin, aspirin, and angio...
Guardat en:
| Publicat a: | Curr Control Trials Cardiovasc Med |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMC
2001
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC64826/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11806810/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/cvm-2-6-263 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|